Profile
Birgit M.
Schoeberl worked as a Director at Silver Creek Pharmaceuticals, Inc. and as the Head-Discovery at Merrimack Pharmaceuticals, Inc. She obtained an undergraduate degree from the University of Karlsruhe.
Former positions of Birgit M. Schoeberl
| Companies | Position | End |
|---|---|---|
| MERRIMACK PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2017-02-23 |
Silver Creek Pharmaceuticals, Inc.
 Silver Creek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Silver Creek Pharmaceuticals, Inc. develops novel regenerative medicines. The firm focuses on treating cardiovascular disease. Its molecules are designed to promote resilience and regeneration of damaged tissues after acute or chronic injury. The company was founded in 2010 and is headquartered in San Francisco, CA. | Director/Board Member | - |
Training of Birgit M. Schoeberl
| University of Karlsruhe | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| MERRIMACK PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Silver Creek Pharmaceuticals, Inc.
Silver Creek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Silver Creek Pharmaceuticals, Inc. develops novel regenerative medicines. The firm focuses on treating cardiovascular disease. Its molecules are designed to promote resilience and regeneration of damaged tissues after acute or chronic injury. The company was founded in 2010 and is headquartered in San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Birgit M. Schoeberl
